Clinical trials for Arthritis, rheumatoid investigate a range of treatment strategies and patient populations.

44 total trials for this combination

Showing top 10 of 44 trials

Trials

NCT ID	Title	Status	Phase
NCT00042068	A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis	COMPLETED	PHASE3
NCT03970837	Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)	TERMINATED	PHASE3
NCT00346216	Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen	COMPLETED	PHASE4
NCT01604343	A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)	COMPLETED	PHASE3
NCT01039688	Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX	COMPLETED	PHASE3
NCT00113308	COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis	COMPLETED	PHASE3
NCT00413699	Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis	COMPLETED	PHASE3
NCT01856309	Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003	COMPLETED	PHASE3
NCT01004432	Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)	COMPLETED	PHASE3
NCT02092467	Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis	COMPLETED	PHASE4

Related Pages

All Arthritis, rheumatoid trials All trials in Duncansville, United States